Manufacturing and quality control data: all parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Investigation: visual inspection: scratches on the outer housing of the valve were observed through the visual inspection.No significant deformations or damages were detected.Permeability test: a permeability test has shown that the valve is permeable.However a partial blockage was indicated by slow drainage during the test.Computer controlled test: to test the opening pressure, we use a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve was tested in the vertical position.The results show that the valve is operating within the accepted tolerance.Results: we have dismantled the valve.Inside the valve we have found a build-up of substances (likely protein).Based on out investigation, we are unable to substantiate the claim of overdrainage.The valve operates within the specified tolerances.However, it is possible that the deposits observed inside the valve could have caused the malfunction in the past.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
|